.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Merck
Dow
Express Scripts
Accenture
Chinese Patent Office
Cantor Fitzgerald
McKesson
Medtronic

Generated: June 28, 2017

DrugPatentWatch Database Preview

VINCRISTINE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Vincristine Sulfate, and what generic Vincristine Sulfate alternatives are available?

Vincristine Sulfate is a drug marketed by Fresenius Kabi Usa, Abraxis Pharm, Hospira, Abic, and Teva Pharms Usa. and is included in nine NDAs.

The generic ingredient in VINCRISTINE SULFATE is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.

Summary for Tradename: VINCRISTINE SULFATE

Patents:0
Applicants:5
NDAs:9
Bulk Api Vendors: see list62
Clinical Trials: see list1,348
Patent Applications: see list9,782
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VINCRISTINE SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION076401-001Oct 28, 2003DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION076296-001Dec 20, 2002DISCNNoNo► Subscribe► Subscribe
Hospira
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION071560-001Apr 11, 1988DISCNNoNo► Subscribe► Subscribe
Hospira
VINCRISTINE SULFATE PFS
vincristine sulfate
INJECTABLE;INJECTION071484-001Apr 19, 1988APRXNoYes► Subscribe► Subscribe
Abraxis Pharm
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION070411-001Sep 10, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Accenture
Merck
Argus Health
Moodys
Fish and Richardson
Medtronic
McKesson
Boehringer Ingelheim
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot